KLOTHO KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Ira Frahmand Driscoll und 15 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin Alzheimer's Disease Research Center and Department of Geriatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wi…. Hauptthemen laut MEDLINE: Klotho Proteins, Biomarkers, Aging, Chitinase-3-Like Protein 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCRR NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
INTRODUCTION We examined whether the aging suppressor KLOTHO gene's functionally advantageous KL‐VS variant (KL‐VS heterozygosity [KL‐VS HET ]) confers resilience against deleterious effects of aging indexed by cerebrospinal fluid (CSF) biomarkers of neuroinflammation (interleukin‐6 [IL‐6], S100 calcium‐binding protein B [S100B], triggering receptor expressed on myeloid cells [sTREM2], chitinase‐3‐like protein 1 [YKL‐40], glial fibrillary acidic protein [GFAP]), neurodegeneration (total α‐synuclein [α‐Syn], neurofilament light chain protein), and synaptic dysfunction (neurogranin [Ng]). METHODS This Alzheimer disease risk‐enriched cohort consisted of 454 cognitively unimpaired adults (M age = 61.5 ± 7.75). Covariate‐adjusted multivariate regression examined relationships between age (mean‐split[age ≥ 62]) and CSF biomarkers (Roche/NeuroToolKit), and whether they differed between KL‐VS HET ( N = 122) and non‐carriers (KL‐VS NC ; N = 332). RESULTS Older age was associated with a poorer biomarker profile across all analytes ( P s ≤ 0.03). In age‐stratified analyses, KL‐VS NC exhibited this same pattern ( P s ≤ 0.05) which was not significant for IL‐6, S100B, Ng, and α‐Syn ( P s ≥ 0.13) in KL‐VS HET . Although age‐related differences in GFAP, sTREM2, and YKL‐40 were evident for both groups ( P s ≤ 0.01), the effect magnitude was markedly stronger for KL‐VS NC . DISCUSSION Higher levels of neuroinflammation, neurodegeneration, and synaptic dysfunction in older adults were attenuated in KL‐VS HET . Highlights Older age was associated with poorer profiles across all cerebrospinal fluid biomarkers of neuroinflammation, neurodegeneration, and synaptic dysfunction. KLOTHO KL‐VS non‐carriers exhibit this same pattern, which is does not significantly differ between younger and older KL‐VS heterozygotes for interleukin‐6, S100 calcium‐binding protein B, neurogranin, and total α‐synuclein. Although age‐related differences in glial fibrillary acidic protein, triggering receptor expressed on myeloid cells, and chitinase‐3‐like protein 1 are evident for both KL‐VS groups, the magnitude of the effect is markedly stronger for KL‐VS non‐carriers. Higher levels of neuroinflammation, neurodegeneration, and synaptic dysfunction in older adults are attenuated in KL‐VS heterozygotes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wisconsin Alzheimer's Disease Research Center and Department of Geriatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Wisconsin Alzheimer's Institute, Madison, Wisconsin, USA.
- Geriatric Research Education and Clinical Center, William S. Middleton VA Hospital, Madison, Wisconsin, USA.
- Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Göteborg, Sweden.
Förderung
- NIA NIH HHS
- NCRR NIH HHS
- NCATS NIH HHS
- NINDS NIH HHS
- Clinical and Translational Science Award
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Driscoll, I. F., Lose, S., Ma, Y., Bendlin, B. B., Gallagher, C., Johnson, S. C., Asthana, S., Hermann, B., Sager, M. A., Blennow, K., Zetterberg, H., Carlsson, C., Kollmorgen, G., Quijano-Rubio, C., Dubal, D., & Okonkwo, O. C. (2024). KLOTHO KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13912
Vancouver
Driscoll IF, Lose S, Ma Y, Bendlin BB, Gallagher C, Johnson SC, et al. KLOTHO KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13912
BibTeX
@article{Driscoll2024,
author = {Driscoll, Ira Frahmand and Lose, Sarah and Ma, Yue and Bendlin, Barbara B and Gallagher, Catherine and Johnson, Sterling C and Asthana, Sanjay and Hermann, Bruce and Sager, Mark A and Blennow, Kaj and Zetterberg, Henrik and Carlsson, Cynthia and Kollmorgen, Gwendlyn and Quijano-Rubio, Clara and Dubal, Dena and Okonkwo, Ozioma C},
title = {KLOTHO KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13912}
}
EUVIMED